this is often cited as 80-95% or near-complete systemic delivery, because it bypasses degradation and enters the bloodstream directly
[3] Because ipamorelin drives endogenous GH rather than delivering pharmacologic GH doses, this threshold is unlikely to be crossed with standard ipamorelin protocols
The REDEFINE 1 and REDEFINE 2 Phase 3 trials used a once-weekly subcutaneous dose of cagrilintide 2.4 mg combined with semaglutide 2.4 mg, reached after roughly 16 weeks of dose titration
The remaining 10% is excreted unchanged via renal elimination
Mangaraj S, Choudhury AK, Swain BM, Sarangi PK, Mohanty BK, Baliarsinha AK
I started semaglutide three weeks ago